Table 2.

Reasons for rivaroxaban or warfarin discontinuation during the study period

RivaroxabanWarfarin
Discontinuation, n, (%) 9 (15) 3 (5) 
 Withdrawal of informed consent 2 1 
 Clinically relevant nonmajor bleeding 2 0 
 Planned pregnancy 3 1 
 Other 2 1 
RivaroxabanWarfarin
Discontinuation, n, (%) 9 (15) 3 (5) 
 Withdrawal of informed consent 2 1 
 Clinically relevant nonmajor bleeding 2 0 
 Planned pregnancy 3 1 
 Other 2 1 
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal